Table 3.

Series I (n = 14): laboratory findings

	After addition of RB before illumination	Day 1	Day 3	Day 5	Day 8
CD62p, %
T-PC	24.7 ± 8.2*	22.8 ± 6.2*	30.2 ± 6.0*	35.2 ± 11.5*	41.7 ± 11.6*
C-PC	15.8 ± 5.2	16.2 ± 5.6	25.7 ± 8.3	28.5 ± 15.4	24.6 ± 9.7
CD62p + TRAP, %
T-PC	65.8 ± 8.9	53.3 ± 13.3*	50.3 ± 10.6*	49.8 ± 10.8*	41.6 ± 10.8
C-PC	61.5 ± 8.7	63.8 ± 12.7	61.8 ± 13.0	62.5 ± 13.8	47.6 ± 13.3
LDH, IU/l
T-PC	179 ± 80	133 ± 46*	147 ± 48*	167 ± 51*	200 ± 47
C-PC	154 ± 57	159 ± 56	169 ± 57	179 ± 57	188 ± 57
Glucose, mmol/1012 cells
T-PC	12.7 ± 0.7*	12.5 ± 1.3*	8.8 ± 0.8*	5.0 ± 1.4*	0.4 ± 0.6*
C-PC	14.5 ± 0.7	14.0 ± 1.1	12.3 ± 0.8	10.3 ± 1.0	7.2 ± 1.3
Lactate, mmol/1012 cells
T-PC	4.1 ± 1.4*	6.0 ± 1.3*	12.3 ± 2.5*	18.9 ± 4.2*	26.6 ± 3.8*
C-PC	3.5 ± 1.1	4.0 ± 1.0	7.7 ± 1.0	10.6 ± 1.6	14.5 ± 3.1

^*p < 0.05; T-PC (PRT-treated unit) versus C-PC (untreated control unit).